FindTrial
Sign In

Prognostic correlation of pathological high-risk factors in early-stage lung adenocarcinoma and the construction and validation of a comprehensive risk prognostic model

Prognostic correlation of pathological high-risk factors in early-stage lung adenocarcinoma and the construction and validation of a comprehensive risk prognostic model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092644
Enrollment
Unknown
Registered
2024-11-20
Start date
2024-11-20
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early-stage invasive lung adenocarcinoma

Interventions

Pathological high-risk factor group:None
Non-pathological high-risk factor group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with stage I solitary primary invasive lung adenocarcinoma who underwent radical resection at West China Hospital, Sichuan University between January 2014 and May 2024.

Exclusion criteria

Exclusion criteria: (1) Missing follow-up data; (2) Previous/current history of malignant tumors; (3) Preoperative neoadjuvant therapy; (4) Postoperative adjuvant therapy

Design outcomes

Primary

MeasureTime frame
Overall survival;Recurrence-free survival;receiver operating characteristic (ROC) curve and area under the curve (AUC);calibration curve;decision curve analysis (DCA);—

Countries

China

Contacts

Public ContactJiandong Mei

West China Hospital of Sichuan University

jiandongmei@aliyun.com+86 189 8060 1762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026